Selenium, an essential biological trace element, has been shown to reduce and prevent the incidence of cancer. Our previous studies have shown that selenite is involved in the chemoprevention of cancer and induction of apoptosis of cancer cells. In this study, we demonstrate that selenite also inhibits the invasion of tumor cells. Cancer cell invasion requires coordinated processes, such as changes in cell-cell and cellmatrix adhesion, degradation of the extracellular matrix, and cell migration. We found that selenite inhibited invasion of HT1080 human fibrosarcoma cells. Adhesion of HT1080 cells to the collagen matrix was also inhibited by treatment with selenite, but cell-cell interaction and cell motility were not affected with selenite. Moreover, selenite reduced expression of matrix metalloproteinase-2,-9 and urokinase type plasminogen activator, which are involved in matrix degradation, but increased a tissue inhibitor of metalloproteinase-1. This inhibitory effect of selenite on the proteases expressions was mediated by the suppression of transcription factors, NF-κB and AP-1. However, selenate showed no remarkable effects on above all the steps of cancer cell invasion.
INTRODUCTION
Metastasis is the major cause of death among cancer patients. The cancer cells metastasis requires several sequential steps, such as changes in cell-1 ECM interaction, disconnection of intercellular adhesions and separation of single cells from solid tumor tissue, degradation of ECM, locomotion of tumor cells into the extracellular matrix, invasion of lymph-and blood vessels, immunologic escape in the circulatory system, adhesion to endothelial cells, extravasation from lymph-and blood vessels, proliferation of cells and induction of angiogenesis (1) .
Attachment of cells to ECM molecules is mediated by the integrin family of extracellular matrix receptors. Integrins are a large family of heterodimeric proteins which transduce a variety of signals from the ECM. Through integrin and matrix interactions, many of the genes, which are critical for cell migration, survival, proliferation, differentiation (2) and ECM degradation, are activated (3, 4) . In the majority of metastasizing tumors, cellular interactions with the ECM, which promote adhesion and migration, are thought to be required for primary tumor invasion, migration and metastasis.
The main groups of proteolytic enzymes involved in the tumor invasion are matrix metalloproteinases (MMPs) and serine proteases. The MMPs, a family of zinc dependent endopeptidases, are involved in tumor invasion, metastasis and angiogenesis in cancer (5) . MMPs are important enzymes for the proteolysis of extracellular matrix proteins such as collagen, proteoglycan, elastin, laminin, and fibronectin (6) . MMPs are synthesized as preproenzymes, and most of them are secreted from the cells as proenzymes. Among human MMPs reported previously, MMP-2 (gelatinase A/ Mr 72,000 type IV collagenase) and MMP-9 (gelatinase B/ Mr 92,000 type IV collagenase) are thought to be key enzymes for degrading type IV collagen, which is a major component of the basement membrane (5) . Both MMP-2 and MMP-9 are abundantly expressed in various malignant tumors (7) , and contribute to invasion and metastasis documented in many reports (8) . The serine proteases, urokinase type plasminogen activator (uPA), can convert plasminogen to plasmin, which is capable of degrading extracellular matrix proteins like fibrin, fibronectin, vitronectin (9) and type IV collagen (10) as well as activating latent forms of MMPs (11) . Therefore, uPA leads to a synergistic effect with MMPs.
Selenium, an essential trace element for animals, has been shown to prevent cancer in numerous animal model systems (12) and cancer chemopreventvie efficacy in humans (13) . The known functions of selenium as an essential element in animals are attributed to ~12 known mammalian selenoproteins, glutathione peroxidase, thioredoxin reductase, phospholipid hydroperoxide, etc., which contain selenocysteine, specifically incorporated through a unique co-translational mechanism (14) . However, the studies of the functions of selenium mainly have been focused on the chemopreventive effects, while the relationship between selenium and metastasis of cancer cells has not been firmly established. Here we demonstrate that selenite decreases the invasiveness of tumor cells in vitro, which is derived from inhibition of cell matrix interaction, suppression of the MMPs and uPA expressions, and upregulation of tissue inhibitor of metalloproteinase-1 (TIMP-1). These results suggest that selenite can contribute to the reduction of invasion and metastasis in tumors.
EXPERIMENTAL PROCEDURES
Cell Culture and Materials-HT1080 (fibrosarcoma), 293 (embryonic kidney) and MDA-MB-231 (breast adenocarcinoma) cells were grown in DMEM supplemented with 10 mM HEPES, 50 mg/L gentamicin (Life Technologies, Inc., Rockville, MD), and 10% heat inactivated fetal bovine serum. T98G (glioblastoma) and NUGC-3 (gastric adenocarcinoma) cells were grown in RPMI 1640 supplemented with 10 mM HEPES, 50 mg/L gentamicin, and 10% heat inactivated fetal bovine serum. Human type I and IV collagens, bovine serum albumin, gelatine, sodium selenite, sodium selenate, plasminogen, fibronogen and thrombin were purchased from Sigma (St. Louis, MO).
Anti-MMP-9, anti-TIMP-1, anti-uPA and anti-uPA inhibitor-1 (uPAI-1) were obtained from Chemicon International, Inc. (Temecula, CA). Matrigel was purchased from Becton Dickinson (Bedford, MA).
Cytotoxicity
Assay-
bromide (MTT) (Roche, Germany) assays were performed as described in supplier's protocol to evaluate the cytotoxicity of selenite and selenate. To confirm this MTT
assay results, we also tested tryphan blue dye exclusion assay. To determine the effect of the selenite and selenate on cell motility, cells were seeded into Transwell on membrane filters coated with 10 µl of type I collagen (0.5 mg/ml) at the bottom of the membrane. Migration in the absence or presence of selenite and selenate was measured as described in the invasion assay.
Cell Invasion and Motility
Zymograhpy-MMP-2 and MMP-9 enzymatic activities were assayed by gelatin zymography (15) . uPA activity was assayed as described previously (16) SDS-polyacrylamide gel, each. After electrophoresis, the gel was washed twice with washing buffer, followed by a brief rinsing in washing buffer without Triton X-100.
The gel was placed on a 0.5% agarose gel containing 0.3% (w/v) fibronogen, 0.1 unit/ml thrombin, 0.2 unit/ml human plasminogen and incubated at 37°C. After incubation, the gel was stained and destained. In this gel, a clear zone of fibrin digestion that appeared indicated the presence of uPA. Cell-Matrix Adhesion Assay-24 well plates were coated with 10 µg/ml of type I collagen or type IV collagen. Nonspecific binding was blocked by PBS containing 2%
Plasmids
bovine serum albumin for 2 h at room temperature. Cells were radiolabeled with Ci/mmol, Amersham Pharmacia Biotech) using a random primer kit (TakaRa, Japan).
The blot was then washed twice with 2 × SSC (300 mM NaCl, 30 mM sodium citrate, pH 7.0) containing 0.05% SDS at 25°C, 0.1 × SSC containing 0.1% SDS at 55°C, and autoradiographed at -70°C.
Western Blot Analysis-Conditioned media were collected and concentrated using Centricon (Millipore, Bedford, MA). Western blot analysis for secreted MMP-9, uPA, TIMP-1, and uPAI-1 was performed according to Burnette's method (17) . show toxic effects to cells, and at media containing 10% FBS, 10 µM selenite showed cytotoxicity (Fig. 1A) . Selenate did not show any cytotoxic effect below 50 µM in the presence or absence of serum (Fig. 1B) . To confirm MTT assay, we performed tryphan blue dye exclusion assay and the results were similar to those of MTT assay, as expected. Noncytotoxic concentration of selenite and selenate was used to further experiments.
RESULTS

Effect of Selenite and Selenate on Proliferation of HT1080 Cells-
Effects of Selenite and Selenate on Invasion and Motility of HT1080 Cells-As
shown in Fig. 2A , invasion of HT1080 cells was significantly reduced by treatment with 1 µM selenite and further inhibited with increased concentrations of selenite. Selenate did not exhibit a significant effect on the invasion at the concentrations used (Fig. 2B ).
However, neither selenite nor selenate showed dramatic changes of motility (Fig. 2, C and D, respectively).
Effects of Selenite and Selenate on Adhesion of HT1080 cells to ECM Proteins and
Cells-Cell-matrix interaction is important for cancer cell invasion because this interaction affects protease expression, tumor cell locomotion and survival. So, we tested whether selenite and selenate affect cell-matrix interaction. When HT1080 cells were preincubated for 6 h with selenium compounds, selenite markedly reduced the cells attachment to type I and type IV collagen in a dose dependent manner (Fig. 3A) .
The attachment of cells to type I collagen was much more affected by selenite than type IV collagen. Unlike selenite, selenate did not significantly affect cell-collagen interactions (Fig. 3B ).
To invade extracellular matrix, tumor cells must dissociate from solid tumors. At this time, cell-cell interaction is loosened. To examine the effects of selenite and selenate on HT1080 cells adhesion to HT1080 cells themselves, a monolayer cell adhesion assay was carried out. Adhesion of HT1080 cells to HT1080 was not changed even after 6 h (Fig. 3, C and D) , and even longer treatment with selenite and selenate (data not shown). (Fig. 4C) activities in a concentration dependent manner, but less effectively decreased MMP-2 activity (Fig. 4A ). Membrane bound uPA activity was also decreased by selenite (data not shown). But, selenate did not show any inhibitory effect on MMP-2, -9 and uPA activities (Fig. 4, B and D) . To confirm that the inhibitory effect of selenite on MMPs in HT1080 cells is general phenomena, several cell lines such as MDA-MB-231, NUGC-3, T98G and 293 cells were further tested. The activities of MMP-9 were dramatically decreased by selenite in these cells, but those of MMP-2 were less dramatic (Fig. 5) .
Effects of Selenite and Selenate on MMPs and uPA Activities-
Effect of Selenite on Stimulatory or Inhibitory Chemicals of MMP-9 expression-
We attempted to detect whether selenite is also effective in the presence of TPA and TNF-α, which are known to up-regulate MMP-9 expression, and activate proMMP-2 to active MMP-2 (19, 20) . Treatment of HT1080 cells with TPA and TNF-α resulted in increased levels of MMP-9 expression, but pretreatment with selenite also decreased level of MMP-9 (Fig. 6, A and B) . The expression and the activation of MMP-2 were much less affected by selenite, as expected. We next treated dexamethasone, which is known to decrease MMP-9 expression (21). When selenite and dexamethasone were treated in cells simultaneously, MMP-9 activity was much more decreased than that of selenite or dexamethasone treated cells only (Fig. 6C) . Unlike selenite, selenate showed no marked effects on MMP-9 activity in all cases (data not shown).
Effects of Selenite and Selenate on Transcription of Proteases and Their Inhibitors-
We further tested whether this strong inhibitory effects of selenite on MMP-9 and uPA are through direct association between selenite and proteases. We performed two experiments. Firstly, we incubated various concentrations of selenite with conditioned media without any HT1080 cells. Direct exposure of collected conditioned medium of HT1080 cells to selenite had no effect on MMPs and uPA gelano-and fibrolytic activities (data not shown), indicating that inhibiton of MMPs and uPA was not attributable to a direct effect of the selenite on secreted MMPs and uPA. Secondly, we performed Western blotting to identify the protein amount. The results of Western blotting showed that selenite decreased MMP-9 and uPA, but increased or didn't change TIMP-1 and uPAI-1 levels (Fig. 7) , respectively.
These two experiments indicate that selenite may exert its actions through the transcriptional regulation of these proteins. Further examination showed that the reduced activities of proteases are related to their mRNA levels. In addition, mRNA levels of their inhibitors were also studied. As shown in Northern blotting results ( Fig.   8 ), selenite decreased MMP-2, MMP-9 and uPA transcriptional levels, and MMP-9 mRNA was dramatically decreased at 3 µM of selenite. Interestingly, selenite increased TIMP-1 mRNA in a dose-dependent manner, but decreased TIMP-2 mRNA level.
This Northern blotting pattern was similar to the results of zymography (Fig. 4 , A and C) and Western blotting (Fig. 7) . However, selenate did not produce much of an effect on MMPs and uPA mRNA levels, as of zymographic analysis, and rather decreased TIMP-1 and short transcript of uPAI-1. Because the mRNA levels of MMP-9 and uPA were markedly decreased by selenite, we further examined using MMP-9 and uPA promoter vectors. In this experiment, selenite reduced the activities of both promoters in a dose-dependent manner (Fig. 9) , which was a similar trend of Northern blotting. All of these results suggest that proteases and their inhibitors are transcriptionally regulated by selenium compounds, especially selenite. expression, and NF-κB is known to regulate MMP-9 and uPA expressions. We then tested the activities of these transcription factors regulated by selenite and selenate using AP-1 and NF-κB reporter vectors, which have binding sites to those factors.
Effects of Selenite and Selenate on NF-κB and AP-1 Activities-
AP-1 and NF-κB activities were significantly decreased by treatment with selenite in the presence as well as in the absence of TPA (Fig. 10 , A and C, respectively), but selenate slightly increased AP-1 and NF-κB activities (Fig. 10, B and D, respectively). transcription factors but also affects signal molecules such as JNK, p38 and PKC (48, 57) . As a result, AP-1 and NF-κB activities could be more strongly inhibited by selenite. From these observations, it can be suggested that selenite inhibits proteases expressions through repression of AP-1 and NF-κB, both directly and indirectly.
AP-1 and NF-κB affect each other (58) (59) (60) and it is known that these factors are involved in inflammation, cell adhesion, cell invasion, metastasis and angiogenesis (5, 61, 62) . From these observations, it has been suggested that suppression of the AP-1
and/or NF-κB activities give potential in blocking tumor initiation, promotion, and metastasis (63), but there have been few reports on the relationship between selenium and antimetastasis. Only recently, it has been reported that selenite and methylselenocysteine inhibit angiogenesis by reduction of intra-tumoral microvessel density and vascular endothelial growth factor (VEGF) expression in mammary carcinomas (64) . Genistein inhibits cell-matrix attachment (65) , downregulates MMPs and uPA, but upregulates TIMP-1, inhibits cell proliferation, angiogenesis and invasion, and induces apoptosis (39, 66, 67) . Therefore, we can suggest that the function of selenite is similar to that of genistein, from our results and other reports mentioned previously. Tumor cells appear to be more sensitive than normal cells by the treatment with selenium compounds (68, 69) . Therefore, treatment with selenium compounds can be utilized to prevent cancer incidence and further to reduce tumor properties, especially metastasis. Further studies of antimetastatic properties of selenite are required. and selenate (D) were treated for 3 days, and fibrin zymography was performed. , and RNA were extracted. RNA were loaded on 1% agarose gels, and
Northern blotting was carried out as described in Materials and Methods. RNA loading was normalized using the signal obtained with a GAPDH cDNA probe. 
